Clinical Trial Update: Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK) [Phase 2]

View source ↗

Summary

Phase 2 study comparing short-incubation Levulan Photodynamic Therapy to vehicle for facial/scalp actinic keratosis has completed, with results posted in Decemb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• LEVULAN Photodynamic Therapy (5-aminolevulinic acid (ALA) for photodynamic therapy)

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2013-12-24